Mitchell Cairo, MD
New York Medical College · New York Medical Center · Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mitchell Cairo, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 21:52 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07575893 · CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaNew York Medical College · not yet recruiting · Classical Hodgkin Lymphoma · principal investigator
- Ph3NCT07225972 · Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC AloneNew York Medical College · recruiting · CMV, AdV Infection, AdV Reactivation · principal investigator
- Ph2NCT05987124 · Defibrotide Dose-escalation for SOS Post-HSCTNew York Medical College · recruiting · Sinusoidal Obstruction Syndrome, Veno-occlusive Disease · principal investigator
- Ph2NCT05564598 · CMV CTLs in Neonates With CMV InfectionNew York Medical College · recruiting · Congenital Cytomegaloviral (CMV) Disease · principal investigator
- Ph2NCT05253495 · Chemoradiotherapy With Targeted Immunotherapy in Pediatric LymphomaNew York Medical College · recruiting · Non-hodgkin Lymphoma, Hodgkin Lymphoma · principal investigator
- Ph1NCT04972942 · Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & LymphomaNew York Medical College · recruiting · T-cell Acute Lymphoblastic Leukemia, T-Cell Acute Lymphoblastic Lymphoma · study chair
- Early Ph1NCT03719105 · Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaNew York Medical College · recruiting · NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma · study director
- Ph2NCT03266653 · EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV InfectionNew York Medical College · recruiting · Epstein-Barr Virus Infections, Primary Immune Deficiency Disorder · principal investigator
- Ph2NCT03266627 · Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus InfectionNew York Medical College · recruiting · Adenovirus, Primary Immune Deficiency Disorder · principal investigator
- N/ANCT03205657 · Auto/Allo Tandem Transplant for Relapsed B-NHLNew York Medical College · completed · Non Hodgkin Lymphoma · principal investigator
- Ph2NCT02675959 · Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell DiseaseNew York Medical College · recruiting · Sickle Cell Disease · principal investigator
- Ph2NCT02393157 · Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLNew York Medical College · recruiting · Non-Hodgkin Lymphoma, Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma · study chair
- Ph1NCT02164097 · ODSH + ICE Chemotherapy in Pediatric Solid TumorsNew York Medical College · terminated · Recurrent Solid Tumor, Refractory Solid Tumor, Sarcoma · principal investigator
- Ph1/Ph2NCT02098512 · Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma PatientsNew York Medical College · unknown · Hodgkin Lymphoma · principal investigator
- Ph1NCT02057445 · 3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated LymphomaNew York Medical College · completed · Non-Hodgkins Lymphoma, Hodgkins Lymphoma, Lymphoproliferative Disorder · principal investigator
- Ph1NCT00684255 · Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)New York Medical College · terminated · Systemic Lupus Erythematosus, Systemic Sclerosis · principal investigator
- Ph2NCT00057811 · Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaChildren's Oncology Group · completed · Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 21:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Children's Oncology Group Chair's GrantU10CA098543 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI PETER C. ADAMSON · fiscal years 2003 to 2013Named on NCT00057811
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.